by Andrew Maynard | Jul 23, 2014 | Health
Neil Hawkins at Dow Chemical tweeted me a link to this piece in the New York Times this morning: A Dearth in Innovation for Key Drugs (Eduardo Porter) There is clearly something wrong with pharmaceutical innovation. Antibiotic-resistant infections sicken more than two...
